Published by ChinaMNC · Hejin
China's Health Sector Reforms: What Foreign Founders Need to Know
A high-level national health conference in Beijing signals policy directions for healthcare, insurance, and pharmaceuticals. For foreign entrepreneurs, this means evolving opportunities in health-related sectors and a compliance landscape that prioritizes public health. Here’s how to navigate company registration and operations in China’s health industry.
What the National Health Conference Means for Your China Business
The National Health and Wellness Conference, held in Beijing on October 12–13, 2026, outlined China’s strategic approach to healthcare for the 15th Five-Year Plan period (2026–2030). While the event itself was a high-level political meeting, the policy directions discussed have practical implications for foreign founders looking to register and operate companies in China’s health sector. Below, we break down the key takeaways and what they mean for your business.
Policy Focus: Health Priority and System Building
President Xi Jinping emphasized that the 15th Five-Year Plan period is critical for achieving the goal of a “Healthy China” by 2035. The strategy includes strengthening the healthcare system, disease prevention, medical services, insurance, pharmaceutical innovation, and talent development. For foreign investors, this signals continued government attention to healthcare infrastructure and services, which may create opportunities in areas such as medical technology, pharmaceuticals, and health management.
Implications for Company Registration
If you are considering setting up a business in China’s health sector, here are the key points to consider:
- Entity choice: Foreign investors can establish a wholly foreign-owned enterprise (WFOE) or a joint venture (JV) with a Chinese partner. The right structure depends on the specific activities (e.g., manufacturing, R&D, services) and whether the sector appears on the Negative List for foreign investment. Healthcare is generally encouraged, but some activities may require Chinese control or partnership.
- Registration steps: The process typically involves name pre-approval, obtaining a business license from the State Administration for Market Regulation (SAMR), and post-registration filings (e.g., tax, customs, foreign exchange). For health-related businesses, additional licenses from the National Medical Products Administration (NMPA) or health commissions may be required.
- Capital requirements: China has largely moved to a subscription capital system, but certain industries (e.g., medical devices) may have minimum capital requirements. Check with local authorities.
- Licenses: Depending on your activities, you may need a Medical Device Business License, Drug Business License, or Health Food License. The government’s focus on food safety and drug quality means stricter supervision—ensure compliance early.
- Tax and compliance: Foreign-invested enterprises are subject to corporate income tax (25%) and value-added tax (VAT). Health-related R&D may qualify for tax incentives. Compliance with data privacy (PIPL) and advertising rules is essential.
Key Policy Directions and Business Opportunities
The conference highlighted several areas that could affect your business strategy:
- Health priority in all policies: The government will integrate health considerations into planning, project approvals, and construction. This means health impact assessments may become more common for certain projects.
- Prevention and public health: Emphasis on disease prevention, healthy lifestyles, and food safety. This could drive demand for health management services, fitness, and nutritious food products.
- Medical service improvements: Focus on primary care, tiered diagnosis and treatment, and chronic disease management. Opportunities exist in telemedicine, digital health, and medical devices for primary care.
- Traditional Chinese Medicine (TCM): Support for TCM innovation and integration with Western medicine. Foreign investment in TCM research and manufacturing may be encouraged.
- Healthcare reform: Coordination of medical services, insurance, and pharmaceuticals. Multi-level insurance systems and centralized procurement may affect pricing and market access for drugs and devices.
- Global health cooperation: Promotion of the “Health Silk Road” and international collaboration. This could facilitate partnerships and knowledge exchange for foreign companies.
Steps to Register a Health-Related Company
Here is a simplified checklist for foreign founders:
- Market research and sector classification: Confirm your business scope and whether it is on the Negative List. Healthcare is generally open, but some sub-sectors (e.g., medical institutions) may have restrictions.
- Choose entity type: WFOE is common for manufacturing and R&D; JV may be required for hospitals or clinics.
- Name pre-approval: Submit to SAMR online.
- Prepare documents: Articles of association, investor identification, registered address proof, and legal representative details.
- Obtain business license: After approval, collect the license.
- Post-registration: Make company seal, open bank account, register with tax and social security authorities.
- Sector-specific licenses: Apply to NMPA for medical devices/drugs, or health commission for medical institutions.
- Tax compliance: Understand VAT, corporate income tax, and possible incentives.
Compliance Considerations
The conference reinforced the importance of food safety, drug quality, and medical ethics. Foreign companies should prioritize quality control and regulatory compliance. Additionally, the government’s focus on “health in all policies” suggests that environmental and occupational health standards may tighten, affecting manufacturing operations.
Conclusion
China’s health sector reforms present both opportunities and regulatory challenges for foreign founders. By understanding the policy direction and following proper registration procedures, you can position your business for success in this evolving market.
Call to action: For assistance with registering and operating a company in China, contact ChinaMNC on WhatsApp/WeChat at +86 153 1898 8535.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.